New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy
Sign Up to like & getrecommendations! Published in 2019 at "Eye"
DOI: 10.1038/s41433-019-0494-z
Abstract: There has been an increase in the range of non-insulin anti-hyperglycaemic agents used to treat type 2 diabetes. With the globally rising rates of type 2 diabetes and complications such as diabetic retinopathy, it is… read more here.
Keywords: diabetic retinopathy; macular oedema; effects diabetic; hyperglycaemic agents ... See more keywords
Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti‐hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes
Sign Up to like & getrecommendations! Published in 2019 at "Diabetic Medicine"
DOI: 10.1111/dme.13835
Abstract: In people with metformin‐treated diabetes, to evaluate the risk of acute pancreatitis, pancreatic cancer and other diseases of the pancreas post second‐line anti‐hyperglycaemic agent initiation. read more here.
Keywords: treatment incretins; risk; risk pancreatic; anti hyperglycaemic ... See more keywords
Changes in incidence of severe hypoglycaemia in people with type 2 diabetes from 2006 to 2016: analysis based on health insurance data in Germany considering the anti‐hyperglycaemic medication
Sign Up to like & getrecommendations! Published in 2020 at "Diabetic Medicine"
DOI: 10.1111/dme.14294
Abstract: To investigate the incidence of severe hypoglycaemia over the past 10 years, taking into account changes in anti‐hyperglycaemic therapy. read more here.
Keywords: hypoglycaemia people; incidence severe; changes incidence; severe hypoglycaemia ... See more keywords
Have we really demonstrated the cardiovascular safety of anti‐hyperglycaemic drugs? Rethinking the concepts of macrovascular and microvascular disease in type 2 diabetes
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.1111/dom.13207
Abstract: A primary goal of the treatment of type 2 mellitus is the prevention of morbidity and mortality associated with cardiovascular disease; however, anti‐hyperglycaemic drugs have the capacity to cause deleterious effects on the circulation, a… read more here.
Keywords: hyperglycaemic drugs; microvascular disease; disease; cardiovascular safety ... See more keywords
Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Global Health"
DOI: 10.1136/bmjgh-2022-010942
Abstract: Objective This study aimed to investigate the preferences regarding risks, benefits and other treatment attributes of patients with type 2 diabetes mellitus (T2DM) in China when selecting a second-line anti-hyperglycaemic medicine. Methods A discrete choice… read more here.
Keywords: medication; hyperglycaemic medication; efficacy; survey ... See more keywords